BioNTech SE (BNTX) Short-term Investments (2018 - 2025)

BioNTech SE has disclosed Short-term Investments across 8 years of filings, most recently posting $8.4 billion for Q4 2025.

• Short-term Investments for Q4 2025 came in at $8.4 billion, up 11.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.4 billion (up 11.73% YoY), and the FY2025 annual result was $8.1 billion, up 8.44% from the prior year.
• Short-term Investments came in at $8.4 billion for Q4 2025 at BioNTech SE, up from $5.2 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $8.4 billion in Q4 2025 to a low of $603118.1 in Q1 2021.
• The 5-year median for Short-term Investments is $3.3 billion (2023), against an average of $3.5 billion.
• Across the five-year window, Short-term Investments plunged 55.73% in 2022 and jumped 27727.46% in 2023, its largest moves.
• BioNTech SE's Short-term Investments stood at $436.5 million in 2021, then slumped by 55.73% to $193.2 million in 2022, then surged by 2620.16% to $5.3 billion in 2023, then soared by 42.75% to $7.5 billion in 2024, then increased by 11.73% to $8.4 billion in 2025.
• The last three Short-term Investments figures came in at $8.4 billion (Q4 2025), $5.2 billion (Q3 2025), and $4.3 billion (Q2 2025), per Business Quant data.